Efficiency and toxmcity of the fludarabine and cyclophosphamide combined therapy in relapsed resistant patients with B-cell chronic lymphocytic leukaemia (CLL) - Polish multicenter study

被引：0
|
作者：
Kowal, M [1 ]
Dmoszynska, A [1 ]
Jawniak, D [1 ]
Lewandowski, K [1 ]
Wegrzyn, J [1 ]
Wolowiec, D [1 ]
Piszcz, J [1 ]
Roznowski, K [1 ]
机构：
[1] Med Acad, Dept Hematooncol, Lublin, Poland
来源：
7TH ANNUAL MEETING OF THE EUROPEAN HAEMATOLOGY ASSOCIATION | 2002年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
We present results of the fludarabine and cyclophosphamide regimen in relapsed/resistant 63 patients with CLL-the first Polish multi- centre trial. Purine analogues (PA) such as fludarabine (F) induce higher remission rates(RR) than conventional chemotherapy in advanced CLL, particulary in patients resistant to alkylating agents (AA)(3, 4). Further studies showed a synergistic activity with other drugs in particular cyclophosphamide (C)(8). The combination of F and C seem to produce a high RR in patients refractory to AA or single-agent of PA. We report here the results of first Polish multicenter study of FC regimen in patients with advanced B-CLL.
引用
收藏
页码：211 / 214
页数：4
相关论文
共 50 条
  • [21] Efficacy and Tolerability Of Frontline Oral Fludarabine and Cyclophosphamide Combination Therapy For Elderly Patients With Chronic B-Cell Lymphocytic Leukaemia and Low Grade Non Hodgkin Lymphoma
    Bergamaschi, Micaela
    Mitscheunig, Laura
    Guolo, Fabio
    Ghiso, Anna
    Galaverna, Federica
    Miglino, Maurizio
    Clavio, Marino
    Ballerini, Filippo
    Canepa, Letizia
    Lemoli, Roberto
    Gobbi, Marco
    Pierri, Ivana
    BLOOD, 2013, 122 (21)
  • [22] Clinical efficacy and safety of combined thalidomide and fludarabine therapy in B-cell chronic lymphocytic leukemia patients.
    Dmoszynska, Anna
    Giannopoulos, Krzysztof
    Kowal, Malgorzata
    Podhorecka, Monika
    Wlasiuk, Paulina
    Bojarska-Junak, Agnieszka
    Trzesniewska, Wioletta
    Rolinski, Jacek
    BLOOD, 2006, 108 (11) : 332B - 332B
  • [23] Combined fludarabine, cyclophosphamide, and alemtuzumab (FCC), an active regimen for treated patients with chronic lymphocytic leukemia (CLL)
    Montillo, Marco
    Miqueleiz, Sara
    Tedeschi, Alessandra
    Ricci, Francesca
    Vismara, Eleonora
    Ciapanna, Denis
    Petrizzi, Valeria Belsito
    Crugnola, Monica
    Spriano, Mauro
    Uziel, Lilj
    De Blasio, Angelo
    Spedini, Pierangelo
    Morra, Enrica
    BLOOD, 2007, 110 (11) : 922A - 922A
  • [24] THE EFFICACY OF FLUDARABINE AND CYCLOPHOSPHAMIDE COMBINATION IN UNTREATED VS PRETREATED PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
    Milosevic, V.
    Bogunovic, M.
    Jankovic, S.
    Antic, D.
    Tomin, D.
    Todorovic, M.
    Kurtovic, N. Kraguljac
    Jovanovic, M. Perunicic
    Bogdanovic, A.
    Mihaljevic, B.
    Gotic, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 527 - 527
  • [25] THE EVALUATION OF EFFICACY AND TOXITY OF THE FIRST LINE THERAPY WITH FLUDARABINE COMBINED WITH CYCLOPHOSPHAMIDE (FC) VERSUS. 2-CHLORODEOXYADENOSINE WITH CYCLOPHOSPHAMIDE (CC) IN CHRONIC LYMPHOCYTIC B-CELL LEUKEMIA (CLL) SUBJECTS - THE OWN STUDY REPORT
    Ceglarek, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 603 - 604
  • [26] Rituximab Maintenance Treatment After Combined Fludarabine, Cyclophosphamide and Rituximab In Previously Untreated Patients with Progressive B-Cell Chronic Lymphocytic Leukemia (CLL): Interim Analysis of An Ongoing Phase II Multicenter Trial On Behalf of the Spanish CLL Study Group (GELLC)
    Garcia-Marco, Jose A.
    Lopez-Jimenez, Javier
    Ferrer, Secundino
    Giraldo, Pilar
    Gonzalez-Barca, Eva
    Navarro, Belen
    Conde, Eulogio
    Gonzalez, Marcos
    Guzman, Jose L.
    Perez, Ernesto
    De la Serna, Javier
    Osma, Mar
    Deben, Guillermo
    Monzo, Encarna
    de Paz, Raquel
    Angeles Ruiz, M.
    Penalver, Francisco-Javier
    Jarque, Isidro
    Banas, Helena
    Carmen Fernandez, M.
    Martinez, Rafael
    Burgaleta, Carmen
    Perez de Oteiza, Jaime
    Angeles Andreu, M.
    Carral, Ana
    Fuentes, Inmaculada
    Donato, Eva
    Leon, Paola
    Carbonell, Felix
    Garcia-Vela, Jose A.
    BLOOD, 2010, 116 (21) : 1016 - 1016
  • [27] Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia, (CLL):: results of a phase II study of the German CLL Study Group
    Hallek, M
    Schmitt, B
    Wilhelm, M
    Busch, R
    Kröber, A
    Fostitsch, HP
    Sezer, O
    Herold, M
    Knauf, W
    Wendtner, CM
    Kuse, R
    Freund, M
    Franke, A
    Schriever, F
    Nerl, C
    Döhner, H
    Thiel, E
    Hiddemann, W
    Brittinger, G
    Emmerich, B
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (02) : 342 - 348
  • [28] 2-CHLORODEOXYADENOSINE FOR PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA RESISTANT TO FLUDARABINE
    DELANNOY, A
    HANIQUE, G
    FERRANT, A
    NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (11): : 812 - 812
  • [29] Oral fludarabine treatment of cutaneous infiltration in a patient with B-cell chronic lymphocytic leukaemia
    Ural, A. U.
    Kubar, A.
    Avcu, F.
    Tastan, H. B.
    Safali, M.
    Nevruz, O.
    Cetin, T.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2007, 32 (02) : 151 - 154
  • [30] In vitro evaluation of fludarabine in combination with cyclophosphamide and/or mitoxantrone in B-cell chronic lymphocytic leukemia
    Bellosillo, B
    Villamor, N
    Colomer, D
    Pons, G
    Montserrat, E
    Gil, J
    BLOOD, 1999, 94 (08) : 2836 - 2843
12345